End-to-End Inventory Control Supports Biotech's Expanding Portfolio

As an innovative biotech expanded its T-cell receptor therapy pipeline, supply chain complexity multiplied. More trials meant tracking additional material types including drug products, cell banks, and drug substances, across a global CMO network.

 

But fragmented spreadsheets and siloed systems created operational bottlenecks, compliance risks, and hours of manual reconciliation that pulled teams away from strategic work. Already leveraging Signant SmartSignals Supplies for Forecasting & Planning, this sponsor took the next critical step by implementing GxP Inventory Essential+.

 

The result: a web-based platform providing centralized, real-time visibility and control from raw material sourcing through production to final distribution, transforming how Quality, Warehouse Management, and Clinical Planning teams collaborate in real time.